1887
Volume 2025, Issue 4
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Nuchal translucency (NT) measurement by ultrasound is used in the first trimester as a screening tool for genetic, chromosomal, and structural anomalies. As the NT measurement increases, the risk of an underlying abnormality also rises. This study aims to evaluate the significance of increased NT measurements within a local cohort, examining their associations with adverse pregnancy outcomes and their potential role in guiding clinical interventions.

Pregnancies with first-trimester fetal NT measurements greater than 2.5 mm were included. Participants were categorized into five groups based on NT measurements: ≤3.4 mm, 3.5–4.4 mm, 4.5–5.4 mm, 5.5–6.4 mm and ≥6.5 mm. The outcomes evaluated included chromosomal anomalies confirmed by invasive testing (such as Trisomy 21), major congenital anomalies involving any major organ system, and miscarriage or termination of pregnancy before 24 weeks of gestation. Gestational age at delivery, birthweight, small-for-dates (SFD) status, and admission to the neonatal intensive care unit (NICU) were evaluated for infants born after 24 weeks of gestation without congenital anomalies.

The median NT measurement among the 290 women in the study was 3.7 mm, ranging from 2.9 mm (25th centile) to 7.4 mm (75th centile). Overall, 43.5% of the participants were in the lowest NT category, while 15.9% were in the highest category. Maternal age, body mass index, and nationality were comparable between the groups. The odds of chromosomal anomalies increased with higher NT measurements, with odds ratio (OR) ranging from 2.50 to 4.02 ( < 0.05), compared to the lowest NT group. Similarly, the odds of major congenital anomalies (OR: 2.20–4.20; < 0.05), multiple anomalies (OR: 5.61–8.19 in the highest three categories; < 0.005), and miscarriages (OR: 5.04–14.9 in the highest three categories; < 0.001) all increased with rising NT measurements. The odds of most chromosomal anomalies increased with NT, except for Trisomy 21, which was similar across the groups. Participants in the two lowest NT groups had 12.7- and 7.5-fold higher odds (both < 0.001) of achieving a pregnancy beyond 24 weeks without anomalies compared to those in the highest NT group. Among pregnancies resulting in viable non-anomalous deliveries, there were no significant differences in the gestational age at delivery, birthweight, incidence of SFD, or NICU admission.

Adverse outcomes, including chromosomal and congenital anomalies, increased with higher NT measurements, with a significant difference observed beyond 3.4 mm. These findings highlight the importance of early NT screening and targeted interventions to improve perinatal outcomes.

© 2025 Adnan, Chilaka, Musa, Vazhiyilethil, Ibrahim, Mohammad Ali, et al., licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2025.103
2025-12-04
2025-12-05

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/qmj/2025/4/qmj.2025.103.html?itemId=/content/journals/10.5339/qmj.2025.103&mimeType=html&fmt=ahah

References

  1. Äyräs O, Tikkanen M, Eronen M, Paavonen J, Stefanovic V. Increased nuchal translucency and pregnancy outcome: A retrospective study of 1063 consecutive singleton pregnancies in a single referral institution. Prenat Diagn. 2013 Sep; 33:(9):856–62. https://doi.org/10.1002/pd.4143
     [Google Scholar]
  2. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol. 2004 Jul; 191:(1):45–67. https://doi.org/10.1016/j.ajog.2004.03.090
     [Google Scholar]
  3. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol. 2008 Apr; 31:(4):376–83. https://doi.org/10.1002/uog.5299
     [Google Scholar]
  4. Sharifzadeh M, Adibi A, Kazemi K, Hovsepian S. Normal reference range of fetal nuchal translucency thickness in pregnant women in the first trimester, one centre study. J Res Med Sci. 2015 Oct; 20:(10):969–73. https://doi.org/10.4103/1735-1995.172786
     [Google Scholar]
  5. Guraya SS. The associations of nuchal translucency and fetal abnormalities; significance and implications. J Clin Diagn Res. 2013 May; 7:(5):936–41. https://doi.org/10.7860/JCDR/2013/5888.2989
     [Google Scholar]
  6. Spataro E, Cordisco A, Luchi C, Filardi GR, Masini G, Pasquini L. Increased nuchal translucency with normal karyotype and genomic microarray analysis: A multicenter observational study. Int J Gynaecol Obstet. 2023 Jun; 161:(3):1040–5. https://doi.org/10.1002/ijgo.14637
     [Google Scholar]
  7. Ozyuncu O, Tanacan A, Fadiloglu E, Unal C, Ziyadova G, Deren O. Impact of increased nuchal translucency values on pregnancy outcomes: A tertiary center experience. Fetal Pediatr Pathol. 2021 Jun; 40:(3):189–97. https://doi.org/10.1080/15513815.2019.1686787
     [Google Scholar]
  8. Roozbeh N, Azizi M, Darvish L. Pregnancy outcome of abnormal nuchal translucency: A systematic review. J Clin Diagn Res. 2017 Mar; 11:(3):QC12–6. https://doi.org/10.7860/JCDR/2017/23755.9384
     [Google Scholar]
  9. Kristensen R, Omann C, Gaynor JW, Rode L, Ekelund CK, Hjortdal VE. Increased nuchal translucency in children with congenital heart defects and normal karyotype—is there a correlation with mortality? Front Pediatr. 2023 Feb 17; 11:1104179. https://doi.org/10.3389/fped.2023.1104179
     [Google Scholar]
  10. Zhao XR, Gao L, Wu Y, Wang YL. Application of chromosomal microarray in fetuses with increased nuchal translucency. J Matern Fetal Neonatal Med. 2020 May; 33:(10):1749–54. https://doi.org/10.1080/14767058.2019.1569622
     [Google Scholar]
  11. Yang D, Yang X, Lei T, Fu F, Li R, Li D, et al. [Application of chromosomal microarray analysis in 815 fetuses with increased nuchal translucency during early pregnancy]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Aug 10; 37:(8):833–8. https://doi.org/10.3760/cma.j.issn.1003-9406.2020.08.007
     [Google Scholar]
  12. Zhou H, Yang X, Yi CX, Zhong H, Yuan S, Pan M, et al. Prenatal diagnosis and early childhood outcome of fetuses with extremely large nuchal translucency. Mol Cytogenet. 2023 Sep 2; 16:(1):22. https://doi.org/10.1186/s13039-023-00650-4
     [Google Scholar]
  13. Bellai-Dussault K, Dougan SD, Fell DB, Lavin Venegas C, Little J, Meng L, et al. Outcomes of pregnancies with varying levels of nuchal translucency measurements: A population-based retrospective study in Ontario, Canada. Acta Obstet Gynecol Scand 2024; 103:2499–510. https://doi.org/10.1111/AOGS.14965
     [Google Scholar]
  14. Lugthart MA, Bet BB, Elsman F, van de Kamp K, de Bakker BS, Linskens IH, et al. Increased nuchal translucency before 11 weeks of gestation: Reason for referral? Prenat Diagn. 2021 Dec; 41:(13):1685–93. https://doi.org/10.1002/pd.6054
     [Google Scholar]
  15. Senat MV, De Keersmaecker B, Audibert F, Montcharmont G, Frydman R, Ville Y. Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype. Prenat Diagn. 2002 May; 22:(5):345–9. https://doi.org/10.1002/pd.321
     [Google Scholar]
  16. Boutot M, Yardin C, Martin R, Bourthoumieu S, Aubard V, Martin S, et al. Follow-up of increased nuchal translucency: Results of a study of 398 cases. J Gynecol Obstet Hum Reprod. 2022 Dec; 51:(10):102482. https://doi.org/10.1016/j.jogoh.2022.102482
     [Google Scholar]
  17. Tarhan T, Kürek Eken M, lhan G, Karateke A. NUKAL TRANSLUSENS ARTMI VE KARYOTP NORMAL GEBELKLERDE PERNATAL SONUÇLARIN DEERLENDRLMES stanbul Tıp Fakültesi Dergisi. 2016; 79:(3):117–21. https://doi.org/10.18017/iuitfd.279883
     [Google Scholar]
  18. Uysal N, Gülümser Ç, Çelik ZY, Yanık FB. Increased nuchal translucency and pregnancy outcomes: Experience of Bakent University Ankara Hospital. Turk J Obstet Gynecol. 2019 Jun; 16:(2):100–6. https://doi.org/10.4274/tjod.galenos.2019.51482
     [Google Scholar]
  19. Bacı M, Uçkan K, ahin HG, Karaaslan O, Karaman E. Increased nuchal translucency and pregnancy outcomes: A tertiary center data. Duzce Med J 2024; 26:(1):38–43. https://doi.org/10.18678/dtfd.1410977
     [Google Scholar]
  20. Zheng J, Wang T, Sun H, Guan Y, Yang F, Wu J, et al. Genetic correlation between fetal nuchal translucency thickening and cystic hygroma and exploration of pregnancy outcome. Sci Rep. 2024 Nov 8; 14:(1):27191. https://doi.org/10.1038/s41598-024-76628-y
     [Google Scholar]
  21. De Domenico R, Faraci M, Hyseni E, Di Prima FA, Valenti O, Monte S, et al. Increased nuchal traslucency in normal karyotype fetuses. J Prenat Med. 2011 Apr-Jun; 5:(2):23–6. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3279164/
     [Google Scholar]
  22. Zalel Y, Zemet R, Kivilevitch Z. The added value of detailed early anomaly scan in fetuses with increased nuchal translucency. Prenat Diagn. 2017 Mar; 37:(3):235–43. https://doi.org/10.1002/pd.4997
     [Google Scholar]
  23. Kelley J, McGillivray G, Meagher S, Hui L. Increased nuchal translucency after low-risk noninvasive prenatal testing: What should we tell prospective parents? Prenat Diagn. 2021 Sep; 41:(10):1305–15. https://doi.org/10.1002/pd.6024
     [Google Scholar]
/content/journals/10.5339/qmj.2025.103
Loading
The impact of increased nuchal translucency on pregnancy outcomes: A retrospective cohort study in Qatar
Qatar Medical Journal 2025, 103 (2025); https://doi.org/10.5339/qmj.2025.103
/content/journals/10.5339/qmj.2025.103
/content/journals/10.5339/qmj.2025.103
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): chromosomal anomalies, congenital anomalies, neonatal health, Nuchal translucency, pregnancy outcomes and Qatar

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error